Increased synergistic effect of egf and igf-i on dna synthesis of cultured psoriatic keratinocytes

Dermatology

Volumn 195, Issue 3, 1997, Pages 213-219

  Ristow, H J ^a,b  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermal growth factor; Growth regulation; Insulin like growth factor; Keratinocyte culture; Psoriasis

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C I 125; SOMATOMEDIN C RECEPTOR; THYMIDINE;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; PSORIASIS; SIGNAL TRANSDUCTION;

EID: 0030856265     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000245945     Document Type: Article

References (20)

1. Gottlieb AB: Immunologic mechanisms in psoriasis. J Invest Dermatol 1990;95(suppl): 18S-19S
2. Bos JD: The pathomechanisms of psoriasis: The skin immune system and cyclosporin. Br J Dermatol 1988;118:141-155.
3. Wong RL. Winslow CM, Cooper KD: The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunol Today 1993: 14:69-74.
4. w, IL-2) suggests a primary immune. but not keratinocyte, pathogenic basis. Nature Med 1995; 1:442-147.
5. Krueger GG, Chambers DA. Shelby J: Involved and univolved skin from psoriatic subjects: Arc they equally diseased? J Clin Invest 1981:68:1548-1557.
6. Weinstein GD, McCullough JI.: Cell proliferation kinetics: in Roenigk HH. Maibach HI (eds): Psoriasis. New York. Dekker. 1991. pp 327-342.
7. Ristow H-J: Effect of insulin-like growth t'ae-lor-I/somatomedin C on thymidine incorporation in cultured psoriatic kcratinocytes after growth arrest in growth factor-free medium. Growth Regul 1993:3:129-137.
8. Cook PW. Mattox PA. Keeble WW. Pittclkow MR. Plowman GD. Shoyab M. Adelman JP. Shipley GD: A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol 1991: 11:1547-1557.
9. Ristow H-J: Studies on stimulation of DNA synthesis with epidermal growth factor and in-sulin-like growth factor-I in cultured human keratinocytes. Growth Regul 1996:6:96-109.
10. Ristow H-J: Interleukin-1 does not stimulate DNA synthesis of cultured human kcratino-cytes growth-arrested in growth factor-depleted medium. J Invest Dermatol 1990:95: 688-692.
11. Milstonc LM. LaVigne JF: Heterogeneity of basal kcratinocytes: Nonrandom distribution of thymidine-labeled basal cells in confluent cultures is not a technical artifact. J Invest Dermatol 1985:84:504-507.
12. Ristow H-J. Mcssmer TO: Basic fibroblast growth factor and insulin-like growth factor I are strong mitogens for cultured mouse keratinocytes. J Cell Physiol 1988:1.37:277-284.
13. Misra P. Nickoloff BJ. Morhenn VB, Hint/RE. Rosenfeld RG: Characterization of insulin-like growth factor somatomedin-C receptors on human keratinocyte monolayers. J Invest Dermatol 1986:87:264-267.
14. Krane JF. Gottlieb AB, Carter DM. Krueger JG: The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis but is differentially regulated from the epidermal growth factor receptor. J Exp Med 1992:175: 1081-1090.
15. Nanaey LB. Yates RA. King LE Jr: Modulation of epidermal growth factor receptors in psoriasis lesions during treatment with topical EGF. J Invest Dcrmtol 1992:98:296-310.
16. Barrandon Y. Green H: Three clonal types of keratinocyte with different capacities for multiplication. Proe Nall Acad Sci USA 1987;84: 2302-2306.
17. Pottcn CS: Cell replacement in epidermis (ker-atopoiesis) via discrete units of proliferation. Int Rev Cytol 1981;69:271-318.
18. Gazit A. Yaich P, Gilon C, Levitzki A: Tyr-phostins I: Synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 1989:32:2344-2352.
19. Sun XJ. Rothenberg P. Kahn CR. Backer JM. Araki E. Wilden PA. Cahill DA. Goldstein BJ, White MF: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991:352:73-77.
20. Stineman RW: A consistently well-behaved method of interpolation. Great Comput 1980:7: 54-57.